Fig. 1From: Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K studyChanges in HbA1c over the 2-year observation period. ANOVA, analysis of variance; HbA1c, hemoglobin A1cBack to article page